The urinary tract infection (UTI) drugs market is experiencing consistent growth due to the increasing prevalence of urinary tract infections across all age groups, rising awareness regarding early diagnosis and treatment, and the growing demand for advanced antimicrobial therapies. The market is also benefiting from improvements in healthcare infrastructure, expanding access to prescription...
SPARK Website
عربي